Cargando…
DNA Methylation in Ovarian Cancer Susceptibility
SIMPLE SUMMARY: It is well established that ovarian cancer “runs in families”, where ovarian and other cancers (commonly breast cancer) occur at early ages at onset and in multiple generations. After decades of genetic studies, rare high-risk genetic mutations in cancer susceptibility genes and over...
Autores principales: | Reid, Brett M., Fridley, Brooke L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795210/ https://www.ncbi.nlm.nih.gov/pubmed/33396385 http://dx.doi.org/10.3390/cancers13010108 |
Ejemplares similares
-
Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome
por: Fridley, Brooke L, et al.
Publicado: (2014) -
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
por: Teschendorff, Andrew E., et al.
Publicado: (2015) -
Epidemiology of ovarian cancer: a review
por: Reid, Brett M., et al.
Publicado: (2017) -
The role of DNA methylation in ovarian cancer chemoresistance: A narrative review
por: Song, Kaiyang, et al.
Publicado: (2023) -
DNA methylation subtypes for ovarian cancer prognosis
por: Yin, Lili, et al.
Publicado: (2021)